Diagnosis and Classification of the Small Round-Cell Tumors of Childhood

Por Cohn, Susan L.
Publicado em 1999

Genetic Discoveries and Treatment Advances in Neuroblastoma

Por Bagatell, Rochelle, Cohn, Susan L.
Publicado no Curr Opin Pediatr (2016)

Neuroblastoma

Por Cheung, Nai-Kong V., Cohn, Susan L.
Publicado em 2005

Using Germline Genomics to Individualize Pediatric Cancer Treatments

Por Pinto, Navin, Cohn, Susan L, Dolan, M. Eileen
Publicado em 2012

New Aspects of Neuroblastoma Treatment: ASPHO 2011 Symposium Review

Por Zage, Peter E., Louis, Chrystal U., Cohn, Susan L.
Publicado em 2012

Second Malignancies in Patients with Neuroblastoma: The Effects of Risk-Based Therapy

Por Applebaum, Mark A., Henderson, Tara O., Lee, Sang Mee, Pinto, Navin, Volchenboum, Samuel L., Cohn, Susan L.
Publicado no Pediatr Blood Cancer (2014)

Presence Of Cancer-Associated Fibroblasts Inversely Correlates With Schwannian Stroma In Neuroblastoma Tumors

Por Zeine, Rana, Salwen, Helen R, Peddinti, Radhika, Tian, Yufeng, Guerrero, Lisa, Yang, Qiwei, Chlenski, Alexandre, Cohn, Susan L
Publicado em 2009

Cross-Talk between Schwann Cells and Neuroblasts Influences the Biology of Neuroblastoma Xenografts

Por Liu, Shuqing, Tian, Yufeng, Chlenski, Alexandre, Yang, Qiwei, Zage, Peter, Salwen, Helen R., Crawford, Susan E., Cohn, Susan L.
Publicado em 2005

Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse

Por Chen, Lindi, Humphreys, Angharad, Turnbull, Lisa, Bellini, Angela, Schleiermacher, Gudrun, Salwen, Helen, Cohn, Susan L., Bown, Nick, Tweddle, Deborah A.
Publicado no Oncotarget (2016)

Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines

Por Salwen Helen R, Guerrero Lisa J, Chlenski Alexandre, Ostler Kelly R, Tian Yufeng, Yang Qiwei, Godley Lucy A, Cohn Susan L
Publicado em 2010-06-01

Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines

Por Yang, Qiwei, Tian, Yufeng, Ostler, Kelly R, Chlenski, Alexandre, Guerrero, Lisa J, Salwen, Helen R, Godley, Lucy A, Cohn, Susan L
Publicado em 2010

Racial and Ethnic Disparities in Risk and Survival in Children With Neuroblastoma: A Children's Oncology Group Study

Por Henderson, Tara O., Bhatia, Smita, Pinto, Navin, London, Wendy B., McGrady, Patrick, Crotty, Catherine, Sun, Can-Lan, Cohn, Susan L.
Publicado em 2011

Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors

Por Chlenski, Alexandre, Guerrero, Lisa J, Peddinti, Radhika, Spitz, Jared A, Leonhardt, Payton T, Yang, Qiwei, Tian, Yufeng, Salwen, Helen R, Cohn, Susan L
Publicado em 2010

Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study

Por Bagatell, Rochelle, London, Wendy B., Wagner, Lars M., Voss, Stephan D., Stewart, Clinton F., Maris, John M., Kretschmar, Cynthia, Cohn, Susan L.
Publicado em 2011

Lung Metastases in Neuroblastoma at Initial Diagnosis: A Report from the International Neuroblastoma Risk Group (INRG) Project

Por DuBois, Steven G., London, Wendy B., Zhang, Yang, Matthay, Katherine K., Monclair, Tom, Ambros, Peter F., Cohn, Susan L., Pearson, Andrew, Diller, Lisa
Publicado em 2008

Clinical Outcome in Children with Recurrent Neuroblastoma Treated with ABT-751 and Effect of ABT-751 on Proliferation of Neuroblastoma Cell Lines and on Tubulin Polymerization In V...

Por Meany, Holly J., Sackett, Dan L., Maris, John M., Ward, Yvona, Krivoshik, Andrew, Cohn, Susan L., Steinberg, Seth M., Balis, Frank M., Fox, Elizabeth
Publicado em 2010

Significance of MYCN Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group Database

Por Bagatell, Rochelle, Beck-Popovic, Maja, London, Wendy B., Zhang, Yang, Pearson, Andrew D.J., Matthay, Katherine K., Monclair, Tom, Ambros, Peter F., Cohn, Susan L.
Publicado em 2009

Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids

Por Chlenski, Alexandre, Dobratic, Marija, Salwen, Helen R., Applebaum, Mark, Guerrero, Lisa J., Miller, Ryan, DeWane, Gillian, Solomaha, Elena, Marks, Jeremy D., Cohn, Susan L.
Publicado no Oncotarget (2016)

Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study

Por London, Wendy B., Frantz, Christopher N., Campbell, Laura A., Seeger, Robert C., Brumback, Babette A., Cohn, Susan L., Matthay, Katherine K., Castleberry, Robert P., Diller, Lisa
Publicado em 2010

Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study

Por Park, Julie R., Scott, Jeffrey R., Stewart, Clinton F., London, Wendy B., Naranjo, Arlene, Santana, Victor M., Shaw, Peter J., Cohn, Susan L., Matthay, Katherine K.
Publicado em 2011